• Home
  • Products
  • About
  • Contact
  • Request A Quote

autolus therapeutics to host investor conference calls

Current Location : Home > autolus therapeutics to host investor conference calls

  • Autolus Therapeutics to host Investor Conference Calls

    May 26 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host investor conference calls

    Get Price
  • Autolus Therapeutics to host Investor Conference Calls

    May 26 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host investor conference calls

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Sep 08 2020 · 18 September 2020Dr. Christian Itin chairman and chief executive officer along with the AUTO3 clinical team will host an investor call and webcast at

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference November 17 2020 at 7 00 AM EST

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    7 December 2020Dr. Christian Itin chairman and chief executive officer along with the Autolus clinical team will host an investor call and webcast at 4.00 pm ET 9.00 pm GMT to discuss

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    LONDON Sept. 08 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 and to

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in

    Get Price
  • Autolus Therapeutics to host Investor Conference Calls

    Autolus Therapeutics to host Investor Conference Calls through June LONDON May 26 2020 -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing

    Get Price
  • Autolus AutolusArix Bioscience

    Apr 01 2021 · Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September. Portfolio Company. Autolus Therapeutics to host Investor Conference Calls through June. Portfolio Company. 22nd May 2020. Autolus Notice of Annual General Meeting (AGM) on Thursday June

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    LONDON Sept. 08 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell

    Get Price
  • Autolus Therapeutics reschedules its investor EHA

    Jun 08 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that it has rescheduled its investor conference call

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in the Jefferies Banking Conference

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and will also participate in the Jefferies Banking Conference

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · LONDON Nov. 17 2020 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO1 and AUTO3 data presented at the American Society of Hematology (ASH) Virtual Congress 2020 and

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · 7 December 2020Dr. Christian Itin chairman and chief executive officer along with the Autolus clinical team will host an investor call and webcast at 4.00 pm ET 9.00 pm GMT to discuss

    Get Price
  • Autolus Therapeutics reschedules its investor EHA

    Jun 08 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that it has rescheduled its investor conference call

    Get Price
  • Autolus Therapeutics Limited (spons. ADRs) hosts

    Mar 03 2021 · The company Autolus Therapeutics Limited (spons. ADRs) is set to host investors and clients on a conference call on 3/4/2021 10 26 30 PM. The call comes after the company s earnings which are

    Get Price
  • Autolus Therapeutics reschedules its investor EHA

    Jun 08 2020 · --Autolus Therapeutics plc a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that it has rescheduled its investor conference call

    Get Price
  • Autolus Therapeutics reschedules its investor EHA

    Jun 08 2020 · Autolus Therapeutics reschedules its investor EHA conference call Conference call and webcast to be held Friday June 12 2020 at 07 30 am

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Sep 08 2020 · 18 September 2020Dr. Christian Itin chairman and chief executive officer along with the AUTO3 clinical team will host an investor call and webcast at

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

      22 September 2020The company will participate in a Q A at the virtual JP CEO Series Investor Call at 11.00 am EDT 4.00 pm BST.About Autolus Therapeutics plcAutolus is a

    Get Price
  • Autolus Therapeutics reschedules its investor EHA

    Jun 08 2020 · After the conference call a replay will be available for one week. To access the replay please dial (855) for U.S. and Canada callers or (404) for international callers. Please

    Get Price
  • Syncona Ltd. (via Public) / Autolus Therapeutics to host

    Autolus Therapeutics plc (Nasdaq AUTL) a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies today announced that management will host an investor conference call to discuss AUTO3 data presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020 and to participate in Banking conferences through September

    Get Price
  • Autolus Therapeutics reschedules its investor EHA

    Jun 08 2020 · Autolus Therapeutics reschedules its investor EHA conference call Conference call and webcast to be held Friday June 12 2020 at 07 30 am

    Get Price
  • Autolus Therapeutics Limited (spons. ADRs) hosts

    Mar 03 2021 · The company Autolus Therapeutics Limited (spons. ADRs) is set to host investors and clients on a conference call on 3/4/2021 10 26 30 PM. The call comes after the company s earnings which are

    Get Price
  • Autolus Therapeutics to host Investor Conference Call to

    Nov 17 2020 · 7 December 2020Dr. Christian Itin chairman and chief executive officer along with the Autolus clinical team will host an investor call and webcast at 4.00 pm ET 9.00 pm GMT to discuss

    Get Price

Products News

    • alumina bricks manufacturerschina kiln refractory bricks factories kiln refractory
    • heavy alkali resistant refractory castables
    • high alumina refractory binder
    • continuous castings metamin a ş
    • optimization of 320t bom for torpedo ladle for
    • directoy of coil coatings manufacturers exporterschina castable for cooling zone of aluminium melting
    • fireplace accessoriesfuel furnaces and refractories by op gupta ebook
    • a castable burn chamber rocket mass heater forum at permies how to homemade castable refractories make homemade
    • kerneos ltd purfleet dolphin way
    • property analysis of alumina refractory bricks aanti spalling high alumina bricks
    • high alumina refractory castable cement maxheat a 1750refractory castable from refractories west
    • engineering ceramics i =𝑌𝜎 𝜋
    • ladle refining furnace

    Product Center

    • Alumina Hollow Ball Bricks
    • Corundum Spinel Castable
    • High Alumina Refractory Cement
    • High Alumina Low Cement Castable
    • High Alumina Refractory Ramming Mass
    • Trough Refractory Castable
    • Magnesium Iron Spinel Brick
    • Mullite Brick
    • Zirconium Mullite Brick

    Hot Products

    • Light Weight Silica Insulation Brick
    • Zirconia Hollow Sphere Brick
    • Corundum Refractory Castable
    • Heavy Alkali Resistant Castable
    • High Alumina Low Cement Castable
    • High Alumina Self Flowing Castable
    • Micro Expansion Refractory Plastic
    • Phosphate Refractory Mud
    • Magnesia Zircon Brick

    Images Show

    About Us

    Rongsheng's main products are various types of unshaped refractory products, which are widely used in metallurgy, nonferrous metals, building materials, electric power, petrochemical and other industries.

    Rongsheng pays attention to technological innovation and product research and development, and has established close cooperative relations with many universities and scientific research institutes.

    Zhengzhou Rongsheng Company © Copyrights. Sitemap